Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FENTANYL | 50MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218137 |
TEVA-FEBUXOSTAT | 80MG | TABLET | Resolved | 2022-07-25 | 2023-01-12 | 165456 |
TEVA-FEBUXOSTAT | 80MG | TABLET | Resolved | 2023-10-05 | 2024-02-08 | 206434 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94877 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94880 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145112 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-11-11 | 2022-01-07 | 149105 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151456 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170784 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2017-05-10 | 2017-09-19 | 9796 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2017-08-01 | 2017-11-06 | 17890 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19941 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2020-06-04 | 2020-06-11 | 116666 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2020-09-03 | 2021-01-07 | 123726 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134331 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136338 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-05-13 | 2021-09-02 | 139300 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141122 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141128 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2022-06-09 | 2022-07-26 | 162291 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
ACT DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
ACT DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
ACT DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
ACT DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |